The Drugs Controller General of India has approved emergency use of drug firm Hetero’s Tocilizumab for treatment of hospitalised adults suffering from Covid-19. Hetero in a statement said that medical practitioners would be able to use the drug for treating Covid-19 in adults who receive systemic corticosteroids, and even those who require supplemental oxygen, non-invasive or […]
\
\
